Stocklytics Platform
Asset logo for symbol CLNN
Clene
CLNN60
$4.35arrow_drop_down1.00%-$0.04
High Growth
Penny Stock
Asset logo for symbol CLNN
CLNN60

$4.35

arrow_drop_down1.00%

Performance History

Chart placeholder
Key Stats
Open$4.37
Prev. Close$4.40
EPS-5.29
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$35.42M
PE Ratio-
LOWHIGH
Day Range4.27
4.74
52 Week Range3.82
12.00
Ratios
Revenue-
EBITDA Margin %-
EPS-5.29

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

About Clene (CLNN)

Clene Inc. (CLNN) is a publicly traded company that develops and commercializes transformative nanotechnology-based therapeutics for the treatment of neurodegenerative diseases. The company is focused on harnessing the power of bioenergetics to restore and repair cellular function in the brain. With a mission to improve the lives of patients suffering from conditions such as Alzheimer's disease and Parkinson's disease, Clene Inc. is at the forefront of cutting-edge research and innovation.
The stock price history of Clene Inc. (CLNN) reflects the company's growth and increasing investor interest. Over the years, the stock has experienced fluctuations in value, responding to market conditions and developments in the neurodegenerative disease space. Investors can track the stock's performance over time to make informed decisions.
As of the latest quote, Clene Inc. (CLNN) is trading at a certain price, reflecting the current market sentiment towards the company. Investors and traders can monitor the quote for real-time updates to stay informed about the stock's movement.
With regards to Clene Inc.'s stock news, it is essential to stay updated on the latest developments and announcements from the company. These news articles can provide valuable insights into Clene Inc.'s ongoing projects, partnerships, clinical trials, regulatory approvals, and other significant milestones. Investors can analyze the news to assess the potential impact on the company's stock price.
Clene Inc.'s stock analysis involves evaluating the company's financial performance, market position, competitive landscape, and future prospects. Analysts use various tools and methodologies to assess the investment potential of Clene Inc.'s stock, taking into account factors such as revenue growth, profitability, margins, and market trends. This analysis helps investors make informed decisions about buying, selling, or holding Clene Inc.'s stock.
To further enhance the stock analysis, Clene Inc. (CLNN) offers smart analysis tools. These sophisticated algorithms leverage artificial intelligence and machine learning techniques to provide valuable insights and predictions about the stock's future performance. Traders and investors can leverage these smart analysis tools to supplement their decision-making process and gain a competitive edge in the market.
One of the key metrics used to assess Clene Inc.'s market value is its market capitalization. Market cap represents the total value of a company's outstanding shares, calculated by multiplying the stock price by the number of shares. Clene Inc.'s market cap reflects the overall investor sentiment and market perception of the company.
The PEG ratio is another important metric that investors consider when evaluating Clene Inc. (CLNN) stock. The PEG ratio compares a company's price-to-earnings (P/E) ratio to its expected growth rate. It provides insights into whether a stock is overvalued or undervalued based on its earnings growth potential. Investors can compare Clene Inc.'s PEG ratio to industry averages to assess its relative valuation.
When comparing Clene Inc. (CLNN) to the industry, investors examine various factors such as financial performance, market share, growth prospects, and competitive advantages. By analyzing Clene Inc.'s position relative to its peers, investors can gain insights into the company's competitive strengths and weaknesses.
The 52-week range of Clene Inc. (CLNN) represents the lowest and highest prices at which the stock has traded over the past year. It shows the stock's volatility and investor sentiment over a 52-week period. Traders can use this range to identify potential buying or selling opportunities based on the stock's price trend.
The day range of Clene Inc. (CLNN) indicates the lowest and highest prices at which the stock has traded during the current trading session. It provides real-time information about the stock's intraday volatility and price movement. Traders can monitor the day range to make timely trading decisions.
The trading volume of Clene Inc. (CLNN) represents the total number of shares that have been traded during a specific period. It indicates the level of investor interest and liquidity in the stock. Higher trading volumes typically suggest higher investor activity and can reflect changes in market sentiment or significant news.
In summary, Clene Inc. (CLNN) is a leading company in the field of nanotechnology-based therapeutics for neurodegenerative diseases. Its stock price history, current quote, and market news provide valuable insights for investors. Stock analysis, including smart analysis tools, helps assess the investment potential of Clene Inc.'s stock. Market cap, PEG ratio, and industry comparisons are factors to consider when evaluating the stock. The 52-week and day ranges reflect the stock's volatility and price movement, while trading volume indicates investor interest and liquidity.
Websitecall_made
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Robert Etherington MBA
Headquarters
Salt Lake City
Employees
75
Exchange
NASDAQ
add Clene to watchlist

Keep an eye on Clene

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Clene's (CLNN) price per share?

The current price per share for Clene (CLNN) is $4.36. The stock has seen a price change of -$0.04 recently, indicating a -1% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Clene (CLNN)?

For Clene (CLNN), the 52-week high is $12, which is 175.48% from the current price. The 52-week low is $3.82, the current price is 14.03% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Clene (CLNN) a growth stock?

Clene (CLNN) has shown an average price growth of -5.18% over the past three years. It has received a score of 98 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Clene as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Clene (CLNN) stock price performance year to date (YTD)?

As of the latest data, Clene (CLNN) has a year-to-date price change of -25.92%. Over the past month, the stock has experienced a price change of 4.46%. Over the last three months, the change has been -2.77%. Over the past six months, the figure is -43.07%.
help

Is Clene (CLNN) a profitable company?

Clene (CLNN) has a net income of -$49.5M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 81.5% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -8.12K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 38.27%, providing insight into the company's sales performance and growth. The gross profit is $533K. Operating income is noted at -$40.54M. Furthermore, the EBITDA is -$34.4M.
help

What is the market capitalization of Clene (CLNN)?

Clene (CLNN) has a market capitalization of $35.43M. The average daily trading volume is 4.54, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level